2-[3-tert-butyl-5-(6-tert-butyl-9-phenylcarbazol-2-yl)carbazol-9-yl]benzene-1,3-dicarbonitrile
C46H38N4 — CID 122418240
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-tert-butyl-5-(6-tert-butyl-9-phenylcarbazol-2-yl)carbazol-9-yl]benzene-1,3-dicarbonitrile
2-[3-tert-butyl-5-(6-tert-butyl-9-phenylcarbazol-2-yl)carbazol-9-yl]benzene-1,3-dicarbonitrile (PubChem CID 122418240) has the molecular formula C46H38N4 and a molecular weight of 646.84 g/mol. Its IUPAC name is 2-[3-tert-butyl-5-(6-tert-butyl-9-phenylcarbazol-2-yl)carbazol-9-yl]benzene-1,3-dicarbonitrile.
Molecular Properties
| Compound Name | 2-[3-tert-butyl-5-(6-tert-butyl-9-phenylcarbazol-2-yl)carbazol-9-yl]benzene-1,3-dicarbonitrile |
|---|---|
| PubChem CID | 122418240 |
| Molecular Formula | C46H38N4 |
| Molecular Weight | 646.84 g/mol |
| Exact Mass | 646.31 |
| IUPAC Name | 2-[3-tert-butyl-5-(6-tert-butyl-9-phenylcarbazol-2-yl)carbazol-9-yl]benzene-1,3-dicarbonitrile |
| SMILES | CC(C)(C)c1ccc2c(c1)c1ccc(-c3cccc4c3c3cc(C(C)(C)C)ccc3n4-c3c(C#N)cccc3C#N)cc1n2-c1ccccc1 |
| InChI | InChI=1S/C46H38N4/c1-45(2,3)32-19-22-39-37(25-32)36-21-18-29(24-42(36)49(39)34-14-8-7-9-15-34)35-16-11-17-41-43(35)38-26-33(46(4,5)6)20-23-40(38)50(41)44-30(27-47)12-10-13-31(44)28-48/h7-26H,1-6H3 |
| InChIKey | FSWFQTTYCPYVKK-UHFFFAOYSA-N |
| XLogP | 11.89 |
| TPSA | 57.44 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 646.84 |
| LogP ≤ 5 | 11.89 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122418240 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.